Insights

Expanding Market Reach AccessDx Laboratory's recent participation in multiple industry events such as the ASCP 2025 and NCDONA conferences demonstrates an active effort to increase market visibility and establish partnerships, presenting opportunities for strategic collaborations and expanding customer base.

Innovative Diagnostic Solutions With proprietary integrated genomic solutions like pharmacogenomics and therapeutic drug monitoring, AccessDx offers unique, high-value diagnostics that can be marketed to healthcare providers seeking advanced personalized medicine options.

Healthcare Integration Recent partnerships with healthcare platforms like PointClickCare and collaborations with organizations like Spartanburg Ob-Gyn highlight a focus on seamless technology integration and enhanced service delivery, opening sales avenues in health IT and clinical integration sectors.

Growing Revenue Potential Having a revenue range of 25 to 50 million dollars and a national licensing coverage suggests a strong financial position with potential for upselling additional testing services, technology solutions, or expanded geographic outreach.

Focus on Personalized Medicine AccessDx’s emphasis on precision medicine and expanding diagnostics, such as the UTI PROx Panel launched in 2023, signals opportunities to present additional targeted testing solutions to healthcare facilities aiming to enhance patient-specific therapeutic strategies.

AccessDx Laboratory Tech Stack

AccessDx Laboratory uses 8 technology products and services including MySQL, Google Fonts API, Flickity, and more. Explore AccessDx Laboratory's tech stack below.

  • MySQL
    Database
  • Google Fonts API
    Font Scripts
  • Flickity
    Javascript Libraries
  • WPBakery
    Page Builders
  • WP Engine
    Platform As A Service
  • Google Analytics
    Web Analytics
  • MonsterInsights
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

AccessDx Laboratory's Email Address Formats

AccessDx Laboratory uses at least 1 format(s):
AccessDx Laboratory Email FormatsExamplePercentage
First.Last@accessdxlab.comJohn.Doe@accessdxlab.com
59%
LFirst@accessdxlab.comDJohn@accessdxlab.com
27%
First@accessdxlab.comJohn@accessdxlab.com
11%
Last@accessdxlab.comDoe@accessdxlab.com
3%

Frequently Asked Questions

Where is AccessDx Laboratory's headquarters located?

Minus sign iconPlus sign icon
AccessDx Laboratory's main headquarters is located at 8920 Kirby Drive Houston, Texas 77054 United States. The company has employees across 2 continents, including North AmericaEurope.

What is AccessDx Laboratory's official website and social media links?

Minus sign iconPlus sign icon
AccessDx Laboratory's official website is accessdxlab.com and has social profiles on LinkedIn.

What is AccessDx Laboratory's SIC code NAICS code?

Minus sign iconPlus sign icon
AccessDx Laboratory's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AccessDx Laboratory have currently?

Minus sign iconPlus sign icon
As of March 2026, AccessDx Laboratory has approximately 63 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: M. S.Chief Revenue Officer (cro): G. S.Chief Compliance Officer: D. D.. Explore AccessDx Laboratory's employee directory with LeadIQ.

What industry does AccessDx Laboratory belong to?

Minus sign iconPlus sign icon
AccessDx Laboratory operates in the Biotechnology Research industry.

What technology does AccessDx Laboratory use?

Minus sign iconPlus sign icon
AccessDx Laboratory's tech stack includes MySQLGoogle Fonts APIFlickityWPBakeryWP EngineGoogle AnalyticsMonsterInsightsApache.

What is AccessDx Laboratory's email format?

Minus sign iconPlus sign icon
AccessDx Laboratory's email format typically follows the pattern of First.Last@accessdxlab.com. Find more AccessDx Laboratory email formats with LeadIQ.

When was AccessDx Laboratory founded?

Minus sign iconPlus sign icon
AccessDx Laboratory was founded in 2016.

AccessDx Laboratory

Biotechnology ResearchTexas, United States51-200 Employees

At AccessDx Laboratory, we are passionate about enhancing and extending patients’ lives by optimizing patient therapy. We believe we are genuinely making an impact on patient's lives - people who are precious to their friends and family.

AccessDx is at the forefront of precision medicine. We are constantly seeking ways to live up to our vision: to make healthcare safer and more effective for every patient through personalized medicine at a cost that can be afforded by society and individuals. 

We provide clinical insights that improve patient outcomes. Only AccessDx has the integrated genomic solutions that provide physicians with the actionable intelligence they need to make more informed therapy decisions.  

AccessDx redefines the patient journey by combining diagnostics such as pharmacogenomics and therapeutic drug monitoring into proprietary solutions. From tumor diagnosis to treatment, AccessDx delivers the clinical insight physicians need while continuing to advance the field with data intelligence. 

AccessDx is currently licensed to run tests in all 50 states including New York, California, and other U.S. territories such as Puerto Rico. The company was founded in 2016 and is headquartered in Houston, TX.

Section iconCompany Overview

Headquarters
8920 Kirby Drive Houston, Texas 77054 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $25M$50M

    AccessDx Laboratory's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    AccessDx Laboratory's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.